{"id":"celbesta","rwe":[{"pmid":"41108024","year":"2025","title":"Systematic review and meta-analysis of analgesic treatment options in patients with rheumatoid arthritis related pain.","finding":"","journal":"Advances in rheumatology (London, England)","studyType":"Clinical Study"},{"pmid":"32589073","year":"2020","title":"Comparison of the efficacy and safety of CELBESTA® versus CELEBREX® in patients with rheumatoid arthritis: a 6-week, multicenter, double-blind, double-dummy, active-controlled, randomized, parallel-group, non-inferiority phase 4 clinical trial.","finding":"","journal":"The Journal of international medical research","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"},{"label":"Dong-A ST Co., Ltd.","category":"company"}],"phase":"marketed","safety":{},"trials":[],"aliases":["celecoxib","celecoxib placebo"],"company":"Dong-A ST Co., Ltd.","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=CELBESTA®","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:51:23.594211+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:51:31.268977+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CELBESTA®","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:51:31.495456+00:00"}},"allNames":["celbesta®"],"offLabel":[],"synonyms":[],"timeline":[],"approvals":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"Celbesta is a small molecule that binds to a specific protein target, modulating its activity through allosteric or competitive inhibition. The exact mechanism of action and target protein are currently unknown, and further research is required to elucidate its pharmacological effects."},"commercial":{},"references":[{"id":1,"url":"https://clinicaltrials.gov/search?intr=celbesta%C2%AE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=celbesta®","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-31T10:32:17.069776","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:51:33.825819+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"celbesta®","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT02780323","phase":"PHASE4","title":"Study to Compare the Efficacy and Safety of CELBESTA® and CELEBREX® in Patients With Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Dong-A ST Co., Ltd.","startDate":"2015-11-02","conditions":["Rheumatoid Arthritis"],"enrollment":119,"completionDate":"2017-12-26"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_enricherVersion":"v2-openfda","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"Dong-A ST Co., Ltd.","relationship":"Original Developer"}],"publicationCount":2,"therapeuticAreas":["Other"],"biosimilarFilings":[],"originalDeveloper":"Dong-A ST Co., Ltd.","recentPublications":[{"date":"2025 Oct 17","pmid":"41108024","title":"Systematic review and meta-analysis of analgesic treatment options in patients with rheumatoid arthritis related pain.","journal":"Advances in rheumatology (London, England)"},{"date":"2020 Jun","pmid":"32589073","title":"Comparison of the efficacy and safety of CELBESTA® versus CELEBREX® in patients with rheumatoid arthritis: a 6-week, multicenter, double-blind, double-dummy, active-controlled, randomized, parallel-group, non-inferiority phase 4 clinical trial.","journal":"The Journal of international medical research"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"CELBESTA®","companyName":"Dong-A ST Co., Ltd.","companyId":"dong-a-st-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:51:33.825819+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}